Stock Details
TEVA is Teva Pharmaceutical Industries Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 9.27$. Average daily volumn in 3 months 13.4M. Market cap 9.19B



Stock symbol : TEVA. Exchange : NYSE. Currency : USD
Lastest price : 8.07$. Total volume : 10.15M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Teva Pharmaceutical Industries Limited (TEVA)
Last Price
8.07$
Change
0.25
Volume
10.15M

Previous Close7.82
Open7.89
Day Range7.85-8.24
Bid8.11 x 1.4k
Ask8.12 x 36.9k
Volume10.15M
Average Volume13.4M
Market Cap9.19B
BetaN/A
52 Week Range6.78-11.34
Trailing P/EN/A
Foward P/E3.16
Dividend (Yield %)N/A
Ex-Dividend DateN/A



Financial Details


According to Teva Pharmaceutical Industries Limited's financial reports the company's revenue in 2021 were 15.88B an decrease(-6.25%) over the years 2020 revenue that were of 16.66B. In 2021 the company's total earnings were 417M while total earnings in 2020 were -3.99B(-113.9%).


Loading ...



Organization

Market Cap:
9.19B
Revenue:
15.88B
Total Assets:
47.67B
Total Cash:
2.17B


News about "Teva Pharmaceutical Industries Limited"

Teva Pharmaceutical Reaches Third State Settlement Over Price-Fixing Claims

Source from : MarketWatch - 1 days ago

By Sabela Ojea Teva Pharmaceutical Industries Ltd. said Friday that it has reached its third settlement agreement with an U.S. attorney general ...See details»


Teva Pharmaceutical Industries Ltd. ADR

Source from : Wall Street Journal - 2 days ago

Vergis Independent Director Dentsply Sirona, Inc., Teva Pharmaceutical Industries Ltd., Dentsply Sirona France SAS, SGS SA, National Association of Corporate Directors, Church & Dwight Co., Inc ...See details»


raymond-james-trust-na-sells-1526-shares-of-teva-pharmaceutical-industries-limited-nyseteva-image

Raymond James Trust N.A. Sells 1,526 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Source from : Defense World - 2 days ago

Raymond James Trust N.A. decreased its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA โ€“ Get Rating) by 5.1% in the second quarter, according to the company in its most recent ...See details»


Teva Pharmaceutical Industries Limited's (NYSE:TEVA) recent 9.3% pullback adds to one-year year losses, institutional owners may take drastic measures

Source from : Nasdaq - 7 days ago

A look at the shareholders of Teva Pharmaceutical Industries Limited (NYSE:TEVA) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with ...See details»


sumitomo-mitsui-ds-asset-management-company-ltd-increases-holdings-in-teva-pharmaceutical-industries-limited-nyseteva-image

Sumitomo Mitsui DS Asset Management Company Ltd Increases Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Source from : Defense World - 5 days ago

Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA โ€“ Get Rating) by 26.8% during the second quarter, according to the ...See details»


TEVA Teva Pharmaceutical Industries Limited

Source from : Seeking Alpha - 9 days ago

**NM signifies a non meaningful value. A dash signifies the data is not available.See details»


Perhaps this is the right time to buy: Teva Pharmaceutical Industries Limited (TEVA)

Source from : investchronicle - 7 days ago

At the end of the latest market close, Teva Pharmaceutical Industries Limited (TEVA) was valued at $8.22. In that particular session, Stock kicked-off at the price of $8.15 while reaching the peak ...See details»


Reasonโ€™s why Teva Pharmaceutical Industries Limited (TEVA) is an asset to your trade with current Target Price of $10.50

Source from : investchronicle - 4 days ago

At the end of the latest market close, Teva Pharmaceutical Industries Limited (TEVA) was valued at $7.90. In that particular session, Stock kicked-off at the price of $7.82 while reaching the peak ...See details»


Erythromelalgia Treatment Market Is Booming Worldwide Teva Pharmaceutical Industries Ltd, Biogen, Pfizer Inc

Source from : Digital Journal - 11 days ago

Some of the Top companies Influencing this Market include:Teva Pharmaceutical Industries Ltd, Biogen, Pfizer Inc, Akorn, Novartis AG, Galderma SA, Acorda Therapeutics, Inc, AbbVie, Amneal ...See details»


Cancer Cachexia Therapy Market Has a Huge Demand to Boost Exponential Growth In 2030 | Top Leading Players: Teva Pharmaceutical Industries Ltd.

Source from : Digital Journal - 29 days ago

Global Cancer Cachexia Therapy market competition by TOP MANUFACTURERS, with production, price, revenue (value), and each manufacturer including: Teva Pharmaceutical Industries Ltd., Sun ...See details»


Marfan Syndrome Management Market Giants Continuously Expanding by: Teva Pharmaceutical Industries Ltd. and Novartis Pharmaceuticals Corporation

Source from : PharmiWeb - 18 days ago

Pune, Maharashtra, India, September 13 2022 (Wiredrelease) Prudour Pvt. Ltd โ€“:Marfan syndrome is a condition that affects the connective tissues in the body. People with Marfan syndrome often have ...See details»


Teva Pharmaceutical Industries Ltd

Source from : Reuters - 3 days ago

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment ...See details»


TEVA Teva Pharmaceutical Industries Limited

Source from : Seeking Alpha - 11 days ago

The chart has 1 X axis displaying Time. Data ranges from 2021-09-20 00:00:00 to 2022-09-20 00:00:00. The chart has 1 Y axis displaying values. Data ranges from -21.06 to 29.See details»


Teva Pharmaceutical Industries Ltd

Source from : Reuters - 2 days ago

25 Oct 2022 / 11:00 AM UTCQ3 2022 Teva Pharmaceutical Industries Ltd Earnings Release 07 Feb 2023 / 12:00 PM UTCQ4 2022 Teva Pharmaceutical Industries Ltd Earnings Release ...See details»